Unity Biotechnology, Inc. (UBX)

NASDAQ: UBX · Delayed Price · USD
0.762
0.002 (0.21%)
At close: May 25, 2022 4:00 PM
0.760
-0.002 (-0.262%)
After-hours:May 25, 2022 5:25 PM EDT

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202120202019201820172016
Selling, General & Admin
23.0624.0320.0516.029.625.14
Research & Development
38.3967.3170.9658.9137.3713.71
Other Operating Expenses
02.630000
Operating Expenses
61.4593.969174.9246.9918.84
Operating Income
-61.45-93.96-91-74.92-46.99-18.84
Interest Expense / Income
3.181.290002.18
Other Expense / Income
-3.9-1.41-8.831.48-2.339.38
Pretax Income
-60.73-93.84-82.18-76.4-44.66-30.4
Net Income
-60.73-93.84-82.18-76.4-44.66-30.4
Net Income Common
-60.73-93.84-82.18-76.4-44.66-30.4
Shares Outstanding (Basic)
5651442833
Shares Outstanding (Diluted)
5651442833
Shares Change
9.73%16.60%54.32%784.12%20.08%-
EPS (Basic)
-1.09-1.84-1.88-2.70-13.97-11.42
EPS (Diluted)
-1.09-1.84-1.88-2.70-13.97-11.42
Free Cash Flow Per Share
-0.81-1.55-1.70-2.05-12.52-7.00
EBITDA
-54.67-89.1-79.51-74.22-43.35-28.07
EBIT
-57.55-92.55-82.18-76.4-44.66-28.22
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).